Eniko Sarvary

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A-status in liver transplant recipients.

Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A-status in liver transplant recipients.

Journal: British journal of clinical pharmacology

Published: May 14, 2020

End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s.

End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s.

Journal: Pharmacological reports : PR

Published: December 16, 2019

Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial.

Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial.

Journal: Therapeutic drug monitoring

Published: December 29, 2016

Analysis of Incretin Hormones After Orthotopic Liver Transplantation.

Analysis of Incretin Hormones After Orthotopic Liver Transplantation.

Journal: Transplantation proceedings

Published: September 13, 2015

Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients.

Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients.

Journal: British journal of clinical pharmacology

Published: April 29, 2015

Endogenous thrombin potential and examination of a further 31 analytes in liver transplant candidates.

Endogenous thrombin potential and examination of a further 31 analytes in liver transplant candidates.

Journal: Transplantation proceedings

Published: August 19, 2014

De novo Prograf versus de novo Advagraf: are trough level profile curves similar?

De novo Prograf versus de novo Advagraf: are trough level profile curves similar?

Journal: Transplantation proceedings

Published: August 19, 2014

New-onset diabetes mellitus and the analysis of dipeptidyl-peptidase-4 after liver transplantation.

New-onset diabetes mellitus and the analysis of dipeptidyl-peptidase-4 after liver transplantation.

Journal: Transplantation proceedings

Published: August 19, 2014

Retransplantations in the Hungarian liver transplant program.

Retransplantations in the Hungarian liver transplant program.

Journal: Transplantation proceedings

Published: December 10, 2013

Recurrence of primary sclerosing cholangitis after liver transplantation - The Hungarian experience.

Recurrence of primary sclerosing cholangitis after liver transplantation - The Hungarian experience.

Journal: Interventional medicine & applied science

Published: September 02, 2013

MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.

MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.

Journal: Journal of gastroenterology and hepatology

Published: August 02, 2013

Hepatitis C virus recurrence after liver transplantation in Hungary. Trends over the past 10 years

Hepatitis C virus recurrence after liver transplantation in Hungary. Trends over the past 10 years

Journal: Orvosi hetilap

Published: July 03, 2013

Showing 1-12 of 20

Last Updated: 09/26/2026